Gateway Investment Advisers LLC Sells 1,957 Shares of Humana Inc. $HUM

Key Points

• Gateway Investment Advisers LLC has reduced its holdings in Humana Inc. by 53.9% during the second quarter, now owning 1,672 shares valued at approximately $409,000.
• Humana's latest quarterly earnings revealed a missed estimate of $0.05 per share, reporting $6.27 against a forecast of $6.32, despite a 9.6% increase in year-over-year revenue amounting to $32.39 billion.
• The company recently declared a quarterly dividend of $0.885, translating to an annualized yield of 1.3%, with the payment scheduled for October 31.

Gateway Investment Advisers LLC cut its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 53.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,672 shares of the insurance provider's stock after selling 1,957 shares during the quarter. Gateway Investment Advisers LLC's holdings in Humana were worth $409,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Fiduciary Alliance LLC increased its holdings in shares of Humana by 34.9% during the second quarter. Fiduciary Alliance LLC now owns 6,976 shares of the insurance provider's stock worth $1,705,000 after purchasing an additional 1,805 shares during the period. Triumph Capital Management increased its holdings in shares of Humana by 28.8% during the second quarter. Triumph Capital Management now owns 2,143 shares of the insurance provider's stock worth $524,000 after purchasing an additional 479 shares during the period. Czech National Bank increased its holdings in shares of Humana by 6.5% during the second quarter. Czech National Bank now owns 29,501 shares of the insurance provider's stock worth $7,212,000 after purchasing an additional 1,792 shares during the period. MassMutual Private Wealth & Trust FSB increased its stake in Humana by 38.4% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 447 shares of the insurance provider's stock valued at $109,000 after acquiring an additional 124 shares during the last quarter. Finally, Atlas Brown Inc. increased its stake in Humana by 0.9% in the second quarter. Atlas Brown Inc. now owns 6,369 shares of the insurance provider's stock valued at $1,557,000 after acquiring an additional 54 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Trading Down 1.5%

HUM opened at $265.22 on Friday. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $324.38. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market cap of $31.90 billion, a P/E ratio of 20.35, a price-to-earnings-growth ratio of 1.58 and a beta of 0.44. The company has a fifty day moving average price of $268.12 and a two-hundred day moving average price of $257.41.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. During the same period last year, the firm posted $6.96 earnings per share. The company's revenue for the quarter was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's payout ratio is 27.17%.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent analyst reports. Piper Sandler decreased their price objective on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research note on Thursday, July 31st. Barclays lifted their price objective on shares of Humana from $275.00 to $315.00 and gave the company an "equal weight" rating in a research note on Friday, September 5th. Robert W. Baird decreased their price objective on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Morgan Stanley decreased their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Finally, Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Seven research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $289.24.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.